Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers

J. J. Dale, C. V. Ruckley, D. R. Harper, B. Gibson, E. Andrea Nelson, R. J. Prescott

Research output: Contribution to journalArticle

Abstract

Objective: To determine whether pentoxifylline 400 mg (Trental 400) taken orally three times daily, in addition to ambulatory compression bandages and dressings, improves the healing rate of pure venous ulcers.
Design: Randomised, double blind placebo controlled trial, parallel group study of factorial design, permitting the simultaneous evaluation of alternative pharmaceutical, bandaging, and dressings materials.
Setting: Leg ulcer clinics of a teaching and a district general hospital in southern Scotland.
Participants: 200 patients with confirmed venous ulcers and in whom other major causal factors were excluded.
Interventions: Pentoxifylline 400 mg three times daily or placebo.
Main outcome measure: Complete healing (full epithelialisation) of all ulcers on the trial leg.
Results: Complete healing occurred in 65 of the 101 (64%) patients receiving pentoxifylline and 52 of the 99 (53%) patients receiving placebo.
Conclusions: The difference in the healing rates between patients taking pentoxifylline and those taking placebo did not reach statistical significance.
Original languageEnglish
Pages (from-to)875-878
Number of pages4
JournalBMJ
Volume319
DOIs
Publication statusPublished - 2 Oct 1999

Keywords

  • leg ulcers
  • pentoxifylline
  • clinical trials
  • treatment

Fingerprint Dive into the research topics of 'Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers'. Together they form a unique fingerprint.

  • Cite this